Preferred Label : Neuropathy, congenital hypomyelinating, 1, autosomal recessive;
Symbol : CHN1;
CISMeF acronym : CHN; CMT4E; CHN1;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Hypomyelination, severe congenital; Charcot-marie-tooth disease, demyelinating, type 4e; Charcot-marie-tooth neuropathy, type 4e; CMT4E; Neuropathy, congenital hypomyelinating or amyelinating, autosomal recessive;
Included titles and symbols : Neuropathy, congenital hypomyelinating, 1, autosomal dominant;
Description : Congenital hypomyelinating neuropathy (CHN) is characterized clinically by early onset
of hypotonia, areflexia, distal muscle weakness, and very slow nerve conduction velocities.
Warner et al. (1997, 1998) noted that pathologic findings on sural nerve biopsies
show hypomyelination of most or all fibers. Based on these findings, CHN is considered
to be a result of congenital impairment in myelin formation. There has been some controversy
and difficulty in differentiating congenital hypomyelination from Dejerine-Sottas
syndrome (DSS; 145900), because there is considerable overlap in clinical presentation.
Based on pathologic findings of sural nerve biopsies (the absence of active myelin
breakdown and the paucity of the onion bulbs in CHN and the presence of demyelination/remyelination
and an abundance of well-organized onion bulbs in DSS; see Balestrini et al., 1991),
CHN is considered to result from a congenital impairment in myelin formation, whereas
DSS is thought to be due to aberrant demyelination and subsequent remyelination of
the peripheral nerve. There is also variation in the prognosis of patients diagnosed
with CHN. In patients with CHN, Harati and Butler (1985) showed correlation of morbidity
and mortality with the presence/absence of onion bulbs: patients with few onion bulbs
died in early infancy, usually because of difficulty in swallowing and respiration
after birth. Patients with atypical onion bulbs survived but were affected with severe
motor and sensory impairment. These differences in outcome may represent genetic heterogeneity
such that mutations in essential early myelin gene(s) cause a severe phenotype, whereas
mutations in other, possibly later acting gene(s), such as MPZ, lead to a less severe
outcome.;
Inheritance : Autosomal recessive; Autosomal dominant (in 1 patient);
Molecular basis : Caused by mutation in the early growth response-2 gene (EGR2, 129010.0001);
Prefixed ID : #605253;
Origin ID : 605253;
UMLS CUI : C4721436;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
False automatic mappings
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT